118 related articles for article (PubMed ID: 17936996)
1. [Development of a biochip for quantitative determination of two forms of prostate specific antigen using internal calibration curve].
Konovalova EV; Savvateeva EN; Dement'eva EI; Filippova MA; Turygin AIu; Osipova TV; Riabykh TP; Rubina AIu; Zasedatelev AS
Mol Biol (Mosk); 2007; 41(4):734-8. PubMed ID: 17936996
[TBL] [Abstract][Full Text] [Related]
2. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients.
Beneduce L; Prayer-Galetti T; Giustinian AM; Gallotta A; Betto G; Pagano F; Fassina G
Cancer Detect Prev; 2007; 31(5):402-7. PubMed ID: 18035503
[TBL] [Abstract][Full Text] [Related]
3. [Development of a rapid method for the detection of prostate-specific antigen by immunochromatography].
Liubavina IA; Zinchenko AA; Lebedin IuS; Chukanov SV
Bioorg Khim; 2007; 33(5):550-4. PubMed ID: 18050661
[TBL] [Abstract][Full Text] [Related]
4. [Immunoassay of nine serological tumor markers on hydrogel-based microchip].
Zubcova ZhI; Savvateeva EN; Butvilovskaia VI; Cybul'skaia MV; Chechetkin VR; Samokhina LO; Vinnitskiĭ LI; Maslennikov VV; Reznikov IuP; Zasedatelev AS; Rubina AIu
Bioorg Khim; 2013; 39(6):693-704. PubMed ID: 25696931
[TBL] [Abstract][Full Text] [Related]
5. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R
Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous detection of free and total prostate specific antigen on a screen-printed electrochemical dual sensor.
Escamilla-Gómez V; Hernández-Santos D; González-García MB; Pingarrón-Carrazón JM; Costa-García A
Biosens Bioelectron; 2009 Apr; 24(8):2678-83. PubMed ID: 19261459
[TBL] [Abstract][Full Text] [Related]
7. CE-based simultaneous liquid-phase noncompetitive enzyme immunoassay for three tumor markers in human serum using electrochemical detection.
Zhang S; Li X; Zhang F
Electrophoresis; 2007 Dec; 28(23):4427-34. PubMed ID: 17979157
[TBL] [Abstract][Full Text] [Related]
8. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA.
Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M
Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403
[TBL] [Abstract][Full Text] [Related]
9. Why 3-D? Gel-based microarrays in proteomics.
Rubina AY; Kolchinsky A; Makarov AA; Zasedatelev AS
Proteomics; 2008 Feb; 8(4):817-31. PubMed ID: 18214844
[TBL] [Abstract][Full Text] [Related]
10. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
[TBL] [Abstract][Full Text] [Related]
11. [The density of prostate specific antigen of the transition zone as an early predictor of prostate cancer].
Topuzov ME; Prialukhin AE; Zhivov AV; Plekhanov AIu
Vestn Khir Im I I Grek; 2008; 167(6):119-21. PubMed ID: 19241832
[TBL] [Abstract][Full Text] [Related]
12. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
Shimbo M; Tomioka S; Sasaki M; Shima T; Suzuki N; Murakami S; Nakatsu H; Shimazaki J
Jpn J Clin Oncol; 2009 Nov; 39(11):727-31. PubMed ID: 19674994
[TBL] [Abstract][Full Text] [Related]
13. [PSA based screening for prostatic cancer].
Johansen TE
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
[No Abstract] [Full Text] [Related]
14. [Prostatic specific antigen: role and significance in urologic practice].
Manolović D; Pejcić T; Milović N
Srp Arh Celok Lek; 1994; 122(5-6):171-3. PubMed ID: 17977420
[TBL] [Abstract][Full Text] [Related]
15. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
[TBL] [Abstract][Full Text] [Related]
16. Total prostate specific antigen stability confirmed after long-term storage of serum at -80C.
Reed AB; Ankerst DP; Leach RJ; Vipraio G; Thompson IM; Parekh DJ
J Urol; 2008 Aug; 180(2):534-7; discussion 537-8. PubMed ID: 18550121
[TBL] [Abstract][Full Text] [Related]
17. Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection.
Schostak M; Schwall GP; Poznanović S; Groebe K; Müller M; Messinger D; Miller K; Krause H; Pelzer A; Horninger W; Klocker H; Hennenlotter J; Feyerabend S; Stenzl A; Schrattenholz A
J Urol; 2009 Jan; 181(1):343-53. PubMed ID: 19012935
[TBL] [Abstract][Full Text] [Related]
18. [Prostate specific antigen: utilization modalities and interpretation].
Hannoun-Levi JM; Ginot A; Thariat J
Cancer Radiother; 2008 Dec; 12(8):848-55. PubMed ID: 18539498
[TBL] [Abstract][Full Text] [Related]
19. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
20. Application of prostate-specific antigen in prostate cancer.
Liang SL
MLO Med Lab Obs; 2008 Oct; 40(10):54, 56-7. PubMed ID: 18988558
[No Abstract] [Full Text] [Related]
[Next] [New Search]
